Molecular subtypes of pancreatic cancer

Collisson, Eric A., Bailey, Peter, Chang, David K., Biankin, Andrew V.·2019·Nature Reviews Gastroenterology & Hepatology
DOI 10.1038/s41575-019-0109-y

Cited by (895)

Items 601–700 of 895

  1. Pathway-specific genomic alterations in pancreatic cancer across diverse cohorts
    Cecilia Monge, Brigette Waldrup, Francisco G. Carranza, Enrique I. Velazquez-Villarreal · 2025 · medRxiv
  2. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation
    Yonghao Xu, Yisu Wang, Qi Chen, Tao Yao, Junyu Qiu, Lei Ni, Hui Chen, Tingbo Liang · 2023 · Pancreatology
  3. Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-catenin
    Yixun Jin, Xinyang Huang, Zhuoxin Wang, Berik Kouken, Qi Wang, Lifu Wang · 2024 · Genes & Diseases
  4. New direction: identification of immunoinflammatory subtypes and potential therapeutic targets for cholangiocarcinoma
    Zhixuan Chen, Honghu Song, Junrui Tang, Jiao Liu, Lina Xia · 2024 · Discover Oncology
  5. Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study
    Lianjing Cao, Huaxin Li, Fang Liu, Tiansuo Zhao, Xiaoya Shi, Han Liu, Yan Kui Sun, Feng Wei, He Ren · 2025 · Clinical Cancer Research
  6. Driving Precision Medicine in Pancreatic Cancer With Molecular Genetics
    Maria Farooq, Michael Jon Pishvaian · 2025 · Seminars in Radiation Oncology
  7. TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma
    Johann Foloppe, Isabelle Farine, Christelle Pichon, Juliette Kempf, Julie Hortelano, Baptiste Moreau, Sandrine Cochin, Armelle Takeda, Patrick Pessaux, Philippe Erbs · 2025 · Frontiers in Microbiology
  8. Prognostic Value of Homologous Recombination Deficiency Identified by Comprehensive Genomic Profiling in Incurable Pancreatic Cancer
    M. Kranjc, U. Cankar, T. Novak · 2024 · Asian journal of Current Research in Clinical Cancer
  9. Metatypic Carcinoma of the Pancreas
    Duygu Atasoy, Burcu Saka, Ayşe Armutlu, Cisel A. Mericoz, Pelin Bağcı, Serdar Balcı, Nuray Tezcan, Irem Guvendir Bakkaloglu, Emre Altınmakas, Emre Bozkurt et al. · 2026 · The American Journal of Surgical Pathology
  10. Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas
    Antonio Pea, Xiaotong T. He, Rosie Upstill-Goddard, Claudio Luchini, Leonor Patricia Schubert Santana, Stephan B. Dreyer, Fraser Duthie, Nigel Balfour Jamieson, Colin J. McKay, Euan J. Dickson et al. · 2026 · Nature Communications
  11. SNHG10 promotes tumorigenesis through the EGFR/AKT/ERK/mTOR and miR-150-5p/VEGF-A axis, along with gemcitabine resistance in pancreatic ductal adenocarcinoma
    Gouri Pandya, Aishwarya Pratap Singh, Suman Saurav, Sharon Raju, Rachana Kumari, Rashi Sharma, Shinjinee Sengupta, Vidhi Goyal, Bhudev C. Das, Gautam Sethi et al. · 2026 · Cell Death Discovery
  12. Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing
    Nina V. Kozlova, Kayla A. Cruz, Antoine A. Ruzette, Hanna M. Doh, Nicholas A. Willis, Su Min Hong, Raul S. González, Monika Vyas, Laura M. Selfors, Stephan B. Dreyer et al. · 2026 · Nature Cell Biology
  13. Reversal of KRAS G12D inhibitor resistance by nimotuzumab via MEK/ERK-mediated unfolded protein response in pancreatic cancer
    Shengbai Xue, Haiyan Xu, Jingyu Ma, Yanling Wang, Wenxin Lu, Jiujie Cui, Liwei Wang · 2026 · Cancer Letters
  14. A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer
    Zhihang Xu, Wenquan Wang, Liang Liu, Wenhui Lou · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  15. Functional Analysis of Molecular Subtypes with Deep Similarity Learning Model Based on Multi-omics Data
    Shuhui Liu, Yupei Zhang, Xuequn Shang · 2022 · Lecture notes in computer science
  16. Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation
    Tiantong Liu, Sihang Cheng, Qiang Xu, Zhiwei Peter Wang · 2022 · Medicina
  17. Efficient Selection of Enhancers and Promoters from MIA PaCa-2 Pancreatic Cancer Cells by ChIP-lentiMPRA
    К. Н. Кашкин, Elena Sergeevna Kotova, И. В. Алексеенко, Svetlana S. Bulanenkova, Sergey B. Akopov, E. P. Kopantzev, Л. Г. Николаев, И. П. Чернов, D. A. Didych · 2022 · International Journal of Molecular Sciences
  18. Identification of characteristic markers correlated with Th2 cell infiltration and metabolism molecular subtype in pancreatic adenocarcinoma
    Zijin Xu, Pengcheng Li, Wenquan Wang, Liang Liu · 2022 · Journal of Gastrointestinal Oncology
  19. Alternative Polyadenylation Characterizes Epithelial and Fibroblast Phenotypic Heterogeneity in Pancreatic Ductal Adenocarcinoma
    Swati Venkat, Michael E. Feigin · 2024 · Cancers
  20. Roles of THEM4 in the Akt pathway: a double-edged sword
    Wen Jun Xie, Weidong Liu, Lei Wang, Bin Zhu, Cong Zhao, Ziling Liao, Yihan Li, Xingjun Jiang, Jie Liu, Caiping Ren · 2024 · Journal of Zhejiang University SCIENCE B
  21. Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives
    Ziyan Zhao, Linan Xing, Qian Cheng, Zhiyi Wu, Fei Xue, Yunyi Peng, Yuxi Zhang, Guixiang Lv, Chunlong Zhang, Chunlong Zhang · 2024 · Journal of Biological Chemistry
  22. Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and Prognosis
    Laura Gutiérrez-Sainz, Victoria Heredia-Soto, Ana Rodríguez, María Gema Crespo Sánchez, María Olmedo, Marta Molero-Luís, Itsaso Losantos-García, Ismael Ghanem, Pablo Pérez-Wert, Ana Belén Custodio et al. · 2024 · International Journal of Molecular Sciences
  23. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications
    Hannah E. Trembath, Jen Jen Yeh, Nicole Lopez · 2024 · Cancer treatment and research
  24. Spatial Organization of Chromatin of the KLF5 Gene Promoter Region in Pancreatic Ductal Adenocarcinoma Cells
    Marina V. Zinovyeva, Л. Г. Николаев · 2024 · Molecular Biology
  25. ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer
    Aideen McCabe, Gerard P. Quinn, Suneil Jain, Micheál Ó. Dálaigh, Kellie A. Dean, Ross G. Murphy, Simon S. McDade · 2024 · BMC Bioinformatics
  26. Serum hsa-miR-22-3p, hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma
    Jakub Szymon Wnuk, Dorota Hudy, Joanna Katarzyna Strzelczyk, Łukasz Michalecki, Kamil Dybek, Iwona Gisterek · 2025 · Current Issues in Molecular Biology
  27. Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer
    Jayasindu Mathiyazhagan, Christabelle Rajesh, Satish Sagar, Thomas C. Caffrey, Ying Huang, Aaron M. Mohs, Benjamin J. Swanson, Michael Anthony Hollingsworth, Cory L. Brooks, Prakash Radhakrishnan · 2025 · Cancers
  28. Robust Consensus Molecular Subtyping of Muscle-Invasive Bladder Cancer Via 3' RNA Sequencing of Formalin-Fixed Paraffin-Embedded Tissues: Potential Impact for Clinical and Trial Settings
    Miriam Angeloni, Sven Wach, Helge Taubert, Danijel Sikic, B. Wullich, Christian Matek, Reiner Strick, Pamela L. Strissel, Arndt Hartmann, Markus Eckstein et al. · 2025 · Laboratory Investigation
  29. Current perspectives and future strategies of chemotherapy for pancreatic cancer: a narrative review
    Hong Jae Chon · 2025 · Journal of Korean Medical Association
  30. Identification of methylation-related genes and the potential regulatory mechanism of SLAMF6 in CMS4 colorectal cancer
    Huimin Liu, Jiyuan Yang, Chunmei Zhao, Guihua Wang, Renfei Lu, Xudong Wang · 2025 · Clinical Epigenetics
  31. Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma
    Pablo Villoslada-Blanco, Lola Alonso, Sergio Sabroso‐Lasa, Miguel Maquedano, Lidia Estudillo, Francisco X. Real, Evangelina López de Maturana, Núria Malats · 2025 · Genome Medicine
  32. WNT7B drives a program for pancreatic cancer subtype switching and progression
    Joep Sprangers, Jeroen M. Bugter, Despina Xanthakis, Michiel Boekhout, Rutger N.U. Kok, Veerle Geurts, Hans C. Clevers, Lodewijk A.A. Brosens, Frederike Dijk, Maria J. Rodríguez Colman et al. · 2026 · iScience
  33. Retrospective analysis by site of primary tumor of patients with unresectable locally-advanced or metastatic pancreatic adenocarcinoma receiving chemotherapy
    Giuseppe A. Colloca, Antonella Venturino, Domenico Guarneri · 2019 · Clinical & Experimental Metastasis
  34. Clinical efficacy evaluation of Erlotinib Combined with Concurrent Chemoradiotherapy in the treatment of locally advanced Pancreatic Cancer
    Ci Liu, Haobin Wei, Yuehong Hou, Zhenlin Gao, Ya-jing Zhang · 2021 · Pakistan Journal of Medical Sciences
  35. Moving Beyond Chemotherapy for Pancreaticobiliary Tumors: Targeted and Immunotherapy Strategies
    Rebecca S. Allen, Naama Halpern, Sandra D. Algaze, Talia Golan, Anthony B. El-Khoueiry, Rachna T. Shroff · 2020 · American Society of Clinical Oncology Educational Book
  36. 928 A translational approach to catalog pancreatic cancer heterogeneity using spatial genomics in large patient cohorts for target validation and rational combination selection
    Omar Jabado, Li Fan, Patrícia Coutinho de Souza, Angelo Harris, Arturo Chaparro, Mohammed Q. Qutaish, Han Si, Jan‐Hermen Dannenberg, Kate Sasser, Suzana S. Couto et al. · 2021 · Regular and Young Investigator Award Abstracts
  37. Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Current Practice
    Georgios Gemenetzis, Siobhan C. McKay, Samir Pathak, John A. G. Moir, Richard Laing, Nigel Balfour Jamieson, Alastair L. Young, Nikolaos A. Chatzizacharias, Francesco Giovinazzo, Keith John Roberts · 2021 · Frontiers in Oncology
  38. Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancer
    Xiangying Deng, He Xu, Zehua Yang, Jing Huang, Lin Zhao, Min Wen, Xiyuan Hu, Zizheng Zou · 2023 · Frontiers in Oncology
  39. Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations
    Anthony Tarabay, Alice Boilève, Cristina Smolenschi, Leony Antoun, Marine Valéry, Alina Cristina Fuerea, Audrey Perret, Pascal C. Burtin, Simona Cosconea, Hichem Belkhodja et al. · 2023 · Biomedicines
  40. Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma
    Bocun Yi, Xifeng Wei, Dongze Liu, Liwei Jing, Shengxian Xu, Man Zhang, Zhengxin Liang, Ranlu Liu, Zhihong Zhang · 2024 · Aging
  41. Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides
    Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Yasuharu Kawamoto, Takeru Hirao, Kazuma Daiku, Shingo Maeda, Makiko Urabe, Yugo Kai et al. · 2024 · Cancer Medicine
  42. Immuno-Oncology in Pancreatic Cancer
    Nigel Balfour Jamieson, Colin William Steele · 2021 · Springer eBooks
  43. Prolonged HPA axis dysregulation in postpartum depression associated with adverse life experiences during development: a cross-species translational study for a novel therapeutic approach
    Minae Niwa, Sedona Lockhart, Daniel J. Wood, Kun Yang, Jose Francis-Oliveira, Kyohei Kin, Adeel Ahmed, Gary S. Wand, Shin‐ichi Kano, Jennifer L. Payne et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Fusobacterium nucleatum induces pancreatic cancer cell proliferation and migration by regulating host autocrine and paracrine signaling
    Barath Udayasuryan, Tam T. D. Nguyen, Ariana Umaña, Raffae N. Ahmad, LaDeidra Monét Roberts, Polina Sobol, Stephen D. Jones, Jennifer M. Munson, Daniel Joseph Slade, Scott S. Verbridge · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?
    Francis P. Robertson, Sanjay Pandanaboyana · 2023 · HepatoBiliary Surgery and Nutrition
  46. Marker-based CRISPR screening reveals a MED12-p63 interaction that activates basal identity in pancreatic ductal adenocarcinoma
    Diogo Maia-Silva, Allison C. Schier, Damianos S. Skopelitis, Vahag Kechejian, Aktan Alpsoy, Jynelle Liverpool, Dylan J. Taatjes, Christopher R. Vakoc · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  47. The prognostic, predictive and clinicopathological impact of KRT81 / HNF1A- and GATA6- based transcriptional subtyping in pancreatic cancer
    Michael Guenther, Sai Agash Surendran, Volker Heinemann, Michael Haas, Stefan Hubert Boeck, Steffen Ormanns · 2024 · medRxiv
  48. Biomarkers in Hepatopancreatobiliary Carcinomas
    Anıl Aysal, Özgül Sağol · 2022 · Springer eBooks
  49. SSH3 promotes pancreatic cancer proliferation and migration by activating the notch signaling pathway
    Chengxiao Yang · 2024 · American Journal of Cancer Research
  50. Claudin 18 turns up the heat in cancer
    Jialin Zhang, Peter M.K. Westcott · 2024 · Immunity
  51. Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-guided treatment of pancreatic cancer
    Maximilian Kordes, Linnéa Malgerud, Jan‐Erik Frödin, Jeffrey Yachnin, Carlos Fernández Moro, Sam H. Ghazi, Raffaella Pozzi Mucelli, Nikolaos Kartalis, Poya Ghorbani, Marco Del Chiaro et al. · 2024 · ESMO Gastrointestinal Oncology
  52. A Recent Overview of the Growing Applications of Biosimilars in Pancreatic Cancer Management: Current Picture and Future Perspectives
    Dhruv Gupta, Daksh Sanjay Gupta, Saritha Rakesh Shetty · 2024 · Springer eBooks
  53. Exploring shared genetic factors and prognostic biomarkers in pancreatic cancer and non-alcoholic fatty liver disease: Focus on hsa-miR-29c-3p and COL11A1 axis
    Ayan Saha, Inan Rahman, Ayan Roy, Nusrat Azad, Paromita Biswas, Ayesha Tasnim Usha, Abul Faisal M.D. Nuruddin Chowdhury, Jannatul Ferdoush · 2024 · Human Gene
  54. Pediatric pancreatic acinar cell carcinoma with a non-canonical BRAF-KMT2C fusion and a classic SND1-BRAF fusion: a case report and literature review
    Yaqin Wang, Zhang Jiasi, Dimin Nie, Ai Zhang, Qun Hu, Aiguo Liu · 2025 · BMC Pediatrics
  55. Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma
    Xing Zhou, Yuhao Ba, Nuo Xu, Hui Xu, Yuyuan Zhang, Long Liu, Siyuan Weng, Shutong Liu, Zhe Xing, Shuang Chen et al. · 2025 · Molecular Medicine
  56. MOGAN for LUAD Subtype Classification by Integrating Three Omics Data Types
    Haibin He, Longxing Wang, Ming-Yue Ma · 2025 · Cancer Innovation
  57. Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
    Dimitrios Papakonstantinou, Haiding Wang, Mohamed Amine Bani, Kevin Mulder, Garett Dunsmore, Alice Boilève, Gérôme Jules-Clément, Leonardo G. Panunzi, Leslie Robert de Sousa, Carlos de la Calle‐Fabregat et al. · 2025 · Cancer Treatment and Research Communications
  58. Synchronous Pancreatic Neoplasms Involving Pancreatic Ductal Adenocarcinoma: A Systematic Review of Case Reports
    Daniel Paramythiotis, Eleni Karlafti, Dimitrios Tsavdaris, Alexandros Mekras, Aris Ioannidis, Stavros Panidis, Elizabeth Psoma, Panos K. Prassopoulos, Antonios Michalopoulos · 2025 · Journal of Personalized Medicine
  59. Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer
    Chi-Hsiu Chung, Kai‐Cheng Hsu, Mingmin Huang, Huang‐Ju Tu, Shiow‐Lin Pan, Min‐Wu Chao · 2025 · Journal of Enzyme Inhibition and Medicinal Chemistry
  60. Histopathological and genetic landscape of pancreatic ductal adenocarcinoma and its variants
    Nicholas J Caldwell, Mingjuan Lisa Zhang · 2025 · Seminars in Diagnostic Pathology
  61. GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma
    Dennis H. Gong, Jimmy A. Guo, Jennifer Su, Sueda Cetinkaya, Connor J. Hennessey, Patrick Z. Yu, Ananya D. Jambhale, Peter L. Wang, Nicholas J Caldwell, Ashley Lam et al. · 2026 · Cell Reports
  62. Heat Shock Proteins in Pancreatic Cancer: Pathogenic Mechanisms and Clinical Implications
    Jacek Kabut, Jakub Sokołowski, Wiktoria Żelazna, Mateusz Stępień, Marta Strauchman, Natalia Jaworska, Jakub Szymon Wnuk, Anita Gorzelak-Magiera, Łukasz Michalecki, Iwona Gisterek · 2025 · Cells
  63. MAFF drives pancreatic cancer progression through AKR1C1-mediated inhibition of ferroptosis
    Xin Jiang, Xuyu Chen, Jianlei Xia, Ben‐Gang Zhou, Aiping Zhang, Yuanyuan Chen, Qiang She, Yaoyao Li, Yanbing Ding, Min Zhang · 2025 · QJM
  64. Single-cell transcriptomic analysis reveals key cell types and pathogenic genes associated with metastasis in pancreatic adenocarcinoma
    Shijun Shen, Zhiqiang Li, Hong Y. Yang, Xinwei Zhang, Gang Chen, Chengzhou Pa · 2025 · Clinical and Experimental Medicine
  65. Immune landscape-driven subtyping reveals distinct microenvironment and prognostic profiles in thymic epithelial tumors
    Yajie Zhang, Tao Lu, Yeke Huang, Xipeng Wang, Xiaoyan Chen, Wei Guo, Youqiong Ye, Hecheng Li · 2025 · npj Precision Oncology
  66. Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer
    Renata Ialchina, Thomas René Simonsen, Henriette Berg Andersen, Arnaud Stigliani, Yifan Dai, Jiayi Yao, Tanja Larsen, Dominika Czaplińska, Luis A. Pardo, Albin Sandelin et al. · 2026 · iScience
  67. Securinine suppresses pancreatic cancer progression by activating the p38 MAPK pathway to upregulate CHOP and induce endoplasmic reticulum stress
    Mengyao Tian, Xuehui Wang, Wangyang Chen, Yuanlin Zhu, Dongchao Xu · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  68. Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer–Associated Fibroblasts
    Hunter D. Reavis, Aditi H. Chaubey, Amanda L. Smythers, Arwen A. Tisdale, Amanda Tracz, Alphonse N. Dimeck, Kathryn E. Maraszek, Eduardo Cortes Gomez, João A. Paulo, Subhamoy Dasgupta et al. · 2026 · Cancer Research Communications
  69. Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets
    Divya Murthy, Attila A. Seyhan, Petra den Hollander, Shaolei Lu, Nick Allen Kuburich, Claire Gould, Andrew Karam, Katie Sun, Patrick G. Schupp, Howard Safran et al. · 2026 · Molecular Aspects of Medicine
  70. Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histological and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor
    Michele Bevere, Antonio Pea, Volkan N. Adsay, Olca Basturk, Lodewijk A.A. Brosens, Irene Esposito, Ralph H. Hruban, David Klimstra, Seung-Mo Hong, Aatur D. Singhi et al. · 2026 · Modern Pathology
  71. Comparative study on PD-L1/ALK dual-targeted biomimetic exosomes by two preparation approaches in pancreatic cancer
    Chenyu Yuan, Yuchen Shi, Xiaohong Liu, Yelin Zhao, Zhilong Ruan, Liaoxin Luo, Li Zhang, Hongjuan Yao, Liang Li · 2026 · International Journal of Biological Macromolecules
  72. Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer
    Namita Bhyravbhatla, Zahraa Wajih Alsafwani, Ishwor Thapa, Palanisamy Nallasamy, Pranita Atri, Carlos M. Moran Segura, Margaret A. Park, Imran Khan, Krystal Villalobos-Ayala, Saravanakumar Marimuthu et al. · 2026 · Gastroenterology
  73. Evolutionarily Conserved Epigenetic Regulation of Transcriptional Cell States During Vertebrate Pancreatic Tumorigenesis
    Somer M. Matar, Sandra Blázquez Araguás, Andrea Diéguez-Docampo, Xiaoying Liu, Annie Katanga, Jordan E. Magurk, Nicole F. Gallien, Michael J Dong, Maria Lao, Nuray Tezcan et al. · 2026 · Cellular and Molecular Gastroenterology and Hepatology
  74. Ferroptosis in pancreatic ductal adenocarcinoma: Mechanisms, tumor biology, and therapeutic opportunities
    Yangchun Xie, Luting Chen, Yuhua Feng, Tao Hou, Rui Kang, Daolin Tang · 2026 · Cancer Letters
  75. The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy
    Yu‐Hsuan Hung, Li‐Tzong Chen, Wen‐Chun Hung · 2022 · Biomedicines
  76. Pathology of Digestive System Malignancies
    Ioannis Parthymos, Redi Bumci, ANNA C. GOUSSIA · 2023 · Springer eBooks
  77. Vitamin D and pancreatic cancer
    Evangelina López de Maturana, Sladjana Zagorac, Núria Malats, Francisco X. Real · 2023 · Elsevier eBooks
  78. Global Burden of Disease Study 2019 Indicates That Smoking Gradually Becomes a Key Driver of the Burden of Pancreatic Cancer in Developing Regions
    Hong Xiang, Deshi Dong, Linlin Lv, Xufeng Tao · 2023 · IntechOpen eBooks
  79. Gaps between needs of patient and public involvement and interests of researchers on pancreatic cancer
    Mathilde Resell, Morten Stranden, Gunnar Qvigstad, Duan Chen, Chun‐Mei Zhao · 2023 · Patient Education and Counseling
  80. The KRAS tour: Studying metabolic reprogramming in isogenic pancreatic cancer organoids
    Shree Bose, Xiling Shen · 2024 · Cell stem cell
  81. Characteristics of Ovarian Cancer Immune Cell Invasion and Bioinformatics to Predict the Effect of Immunotherapy
    L.-N. Yan, Erxi Fan, Bin Tan · 2024 · Hormone and Metabolic Research
  82. Alternative Splicing in Pancreatic Ductal Adenocarcinoma Leads to Dysregulated Immune System
    Fatimah A. Abdul Jabbar, Rawaa AlChalabi, Ahmed Yaseen AL-Tarboolee, Semaa Abdulrahman Shaban, Ahmed AbdulJabbar Suleiman · 2024 · Mathematical Biology and Bioinformatics
  83. Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma
    Xiaopeng Chen, Zhaohui Chen, Jianyang Guo, Zhe Xiu, Huangxiang Chen · 2024 · Frontiers in Oncology
  84. Mixed pancreatic ductal adenocarcinoma and well-differentiated neuroendocrine tumor: A case report
    Xiaofeng Zhao, Tina Bocker Edmonston, Ronald Miick, Upasana Joneja · 2024 · World Journal of Gastrointestinal Oncology
  85. No Evidence for Distinct Transcriptomic Subgroups of Devil Facial Tumor Disease ( DFTD )
    Cleopatra Petrohilos, Emma Peel, Kimberley C. Batley, Samantha Fox, Carolyn J. Hogg, Katherine Belov · 2025 · Evolutionary Applications
  86. The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy
    Elena Crecca, Gianfranco Di Giuseppe, C Camplone, Virginia Vigiano Benedetti, Ombretta Melaiu, Teresa Mezza, Chiara Cencioni, Francesco Spallotta · 2025 · Pharmacology & Therapeutics
  87. Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer
    Veronica Zelli, Alessandra Corrente, Chiara Compagnoni, Francesco Colaianni, Martina Sara Miscione, Monica Di Padova, Daria Capece, Gaetano Barbato, Edoardo Alesse, Francesca Zazzeroni et al. · 2025 · Cancers
  88. Bibliometric analysis of global research trends in pancreatic cancer immunotherapy
    Tong Fu, Yuqing Chen, Hao Wang, Linlin He, Jian Zhang, Yongping Zhou, Xuchu Duan, Xu Zhang · 2025 · Human Vaccines & Immunotherapeutics
  89. Therapeutic Targeting of Stromal Components
    Albrecht Neeße · 2020 · Molecular and translational medicine
  90. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long‐Term Survival in Pancreatic Cancer
    Zhiqiang Zhang, Jiangning Gu, Menghong Yin, Di Wang, Chi Ma, Jian Du, Zhikun Lin, Siling Hu, Xuelong Wang, Ying Li et al. · 2020 · BioMed Research International
  91. Molecular Subtyping of Pancreatic Cancer
    Stephan B. Dreyer, Nigel Balfour Jamieson, David Kuang-Fu Chang, Andrew Victor Biankin · 2021 · Springer eBooks
  92. Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle
    Pratibha Malhotra, Ranjith Palanisamy, Marco Falasca · 2021 · Hepatobiliary & pancreatic diseases international
  93. A novel empeROR of pancreatic malignancy
    Irene Peñuelas‐Haro, Elisa Espinet · 2023 · The EMBO Journal
  94. Putting the Cell of Origin for Pancreatic Cancer Into its Proper Context
    Howard C. Crawford · 2019 · Cellular and Molecular Gastroenterology and Hepatology
  95. Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice
    Akhil Chawla, Andrew J. Aguirre · 2021
  96. Multi-dimensional analyses identify genes of high priority for pancreatic cancer research
    Zeribe C. Nwosu, Heather Giza, Maya Nassif, Verodia Charlestin, Rosa Elena Menjivar, Daeho Kim, Samantha B. Kemp, Nina G. Steele, Jiantao Hu, Biao Hu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  97. The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response—Letter
    Tessa Y. S. Le Large, Lenka N.C. Boyd, Geert Kazemier M, Elisa Giovannetti · 2021 · Clinical Cancer Research
  98. An Investigation of Point Mutations Discovers Novel Genes and Their Corresponding Motifs in Pancreatic Cancer
    Amin Ghareyazi, Amir Mohseni, Hamed Dashti, Abdollah Dehzangi, Hamid Reza Rabiee, Hamid Alinejad‐Rokny · 2021 · Preprints.org
  99. The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response—Response
    Henry C.-H. Law, Emalie J. Clement, Paul M. Grandgenett, Michael Anthony Hollingsworth, Nicholas T. Woods · 2021 · Clinical Cancer Research
  100. Data from hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma
    Sheron Perera, Gun Ho Jang, Yifan Wang, Deirdre Kelly, Michael J. Allen, Amy Xin Wei Zhang, Robert Edward Denroche, Anna Dodd, Stephanie Ramotar, Shawn Hutchinson et al. · 2023